Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Doi

Showing results (461-470 of 494) with videos related to

Pageof 50
Sort By:
The Journal of Infectious Diseases|September 30, 2016
CD36 Provides Host Protection Against Klebsiella pneumoniae Intrapulmonary Infection by Enhancing Lipopolysaccharide Responsiveness and Macrophage PhagocytosisTolani F Olonisakin, Huihua Li, Zeyu Xiong, et al.
Open Forum Infectious Diseases|October 14, 2017
A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant <i>Enterobacteriaceae</i>Oryan Henig, Eric Cober, Sandra S Richter, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2022
A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream InfectionsCourtney L Luterbach, Hongqiang Qiu, Patrick O Hanafin, et al.
Open Forum Infectious Diseases|January 12, 2019
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant <i>Enterobacteriaceae</i>Courtney L Luterbach, Ashley Boshe, Heather I Henderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2017
High Rates of Human Fecal Carriage of mcr-1-Positive Multidrug-Resistant Enterobacteriaceae Emerge in China in Association With Successful Plasmid FamiliesLan-Lan Zhong, Hang T T Phan, Cong Shen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on MortalityLaura J Rojas, Madiha Salim, Eric Cober, et al.
Mbio|March 21, 2022
Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial ResistanceAlina Iovleva, Mustapha M Mustapha, Marissa P Griffith, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 10, 2025
A feasibility study for personalized phage therapy against drug-resistant bacteria in JapanKayoko Hayakawa, Kotaro Kiga, Shinjiro Ojima, et al.
BMC Infectious Diseases|July 7, 2026
Distinct molecular epidemiology and outcomes of carbapenem-resistant gram-negative infections in Lebanon: insights from the MDRO networkJean-Francois Jabbour, Hind Kadri, Elio Jabra, et al.
Infection Control and Hospital Epidemiology|May 16, 2019
Use of a cohorting-unit and systematic surveillance cultures to control a Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae outbreakAllison E Reeme, Sarah L Bowler, Blake W Buchan, et al.
Pageof 50

Showing results (461-470 of 494) with videos related to

Sort By:
Pageof 50
The Journal of Infectious Diseases|September 30, 2016
CD36 Provides Host Protection Against Klebsiella pneumoniae Intrapulmonary Infection by Enhancing Lipopolysaccharide Responsiveness and Macrophage PhagocytosisTolani F Olonisakin, Huihua Li, Zeyu Xiong, et al.
Open Forum Infectious Diseases|October 14, 2017
A Prospective Observational Study of the Epidemiology, Management, and Outcomes of Skin and Soft Tissue Infections Due to Carbapenem-Resistant <i>Enterobacteriaceae</i>Oryan Henig, Eric Cober, Sandra S Richter, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2022
A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream InfectionsCourtney L Luterbach, Hongqiang Qiu, Patrick O Hanafin, et al.
Open Forum Infectious Diseases|January 12, 2019
The Role of Trimethoprim/Sulfamethoxazole in the Treatment of Infections Caused by Carbapenem-Resistant <i>Enterobacteriaceae</i>Courtney L Luterbach, Ashley Boshe, Heather I Henderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2017
High Rates of Human Fecal Carriage of mcr-1-Positive Multidrug-Resistant Enterobacteriaceae Emerge in China in Association With Successful Plasmid FamiliesLan-Lan Zhong, Hang T T Phan, Cong Shen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 13, 2016
Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on MortalityLaura J Rojas, Madiha Salim, Eric Cober, et al.
Mbio|March 21, 2022
Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial ResistanceAlina Iovleva, Mustapha M Mustapha, Marissa P Griffith, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 10, 2025
A feasibility study for personalized phage therapy against drug-resistant bacteria in JapanKayoko Hayakawa, Kotaro Kiga, Shinjiro Ojima, et al.
BMC Infectious Diseases|July 7, 2026
Distinct molecular epidemiology and outcomes of carbapenem-resistant gram-negative infections in Lebanon: insights from the MDRO networkJean-Francois Jabbour, Hind Kadri, Elio Jabra, et al.
Infection Control and Hospital Epidemiology|May 16, 2019
Use of a cohorting-unit and systematic surveillance cultures to control a Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae outbreakAllison E Reeme, Sarah L Bowler, Blake W Buchan, et al.
Pageof 50